Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of fatty acid synthesis induces differentiation and reduces tumor burden in childhood neuroblastoma
María Victoria Ruiz-Pérez, Lourdes Sainero‐Alcolado, Ganna Oliynyk, et al.
iScience (2021) Vol. 24, Iss. 2, pp. 102128-102128
Open Access | Times Cited: 24

Showing 24 citing articles:

MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma
Ling Tao, Mahmoud A. Mohammad, Giorgio Milazzo, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 43
Discovery of PPAR Alpha Lipid Pathway Modulators That Do Not Bind Directly to the Receptor as Potential Anti-Cancer Compounds
Arwa Al Subait, Raghad Alghamdi, Rizwan Ali, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 736-736
Open Access | Times Cited: 1
Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance
C. Raman Suri, Babita Pande, Lakkakula Suhasini Sahithi, et al.
Cancer Drug Resistance (2025)
Open Access | Times Cited: 1
Targeting fatty acid uptake and metabolism in cancer cells: A promising strategy for cancer treatment
Rahul Mallick, Prasenjit Bhowmik, Asim K. Duttaroy
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115591-115591
Open Access | Times Cited: 12
Orchestral role of lipid metabolic reprogramming in T-cell malignancy
Arundhati Mehta, Yashwant Kumar Ratre, Vivek Kumar Soni, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
Histone Acyl Code in Precision Oncology: Mechanistic Insights from Dietary and Metabolic Factors
Sultan Abda Neja, Wan Mohaiza Dashwood, Roderick H. Dashwood, et al.
Nutrients (2024) Vol. 16, Iss. 3, pp. 396-396
Open Access | Times Cited: 4
New UB006 Derivatives With Higher Solubility and Cytotoxic Activity in Ovarian Cancer Cells
Manuel Reina, Xavier Ariza, Dolors Serra, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 194-194
Open Access
Anti‐Tumor Strategies Targeting Nutritional Deprivation: Challenges and Opportunities
Jinsheng Shi, Wei Han, Jie Wang, et al.
Advanced Materials (2025)
Closed Access
Targeting tumor angiogenesis and metabolism: a new perspective in pediatric thoracic tumor therapy
Yong Lv, F. Shu, Dan Luo, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Metabolic Reprogramming of the Tumor Microenvironment to Enhance Response to Immunotherapy
Seon Ah Lim
BMB Reports (2024) Vol. 57, Iss. 9, pp. 388-399
Open Access | Times Cited: 3
Fatty acid synthase (FASN) signalome: A molecular guide for precision oncology
Javier A. Menéndez, Elisabet Cuyàs, José Antonio Encinar, et al.
Molecular Oncology (2023) Vol. 18, Iss. 3, pp. 479-516
Open Access | Times Cited: 7
The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome
Francesco Rugolo, Nicolás G. Bazán, Jorgelina M. Calandria, et al.
Oncogene (2021) Vol. 40, Iss. 38, pp. 5741-5751
Closed Access | Times Cited: 17
Unsaturated Fatty Acid Synthesis Is Associated with Worse Survival and Is Differentially Regulated by MYCN and Tumor Suppressor microRNAs in Neuroblastoma
Dennis A. Sheeter, Secilia Garza, Hui Gyu Park, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1590-1590
Open Access | Times Cited: 2
Defining neuroblastoma: from origin to precision medicine
Lourdes Sainero‐Alcolado, Tomas Sjöberg Bexelius, Giuseppe Santopolo, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 12, pp. 2174-2192
Open Access | Times Cited: 2
Targeting lipid metabolism in cancer: neuroblastoma
Massimiliano Agostini, Gerry Melino, Bola Habeb, et al.
Cancer and Metastasis Reviews (2022) Vol. 41, Iss. 2, pp. 255-260
Open Access | Times Cited: 10
Expression and activation of nuclear hormone receptors result in neuronal differentiation and favorable prognosis in neuroblastoma
Lourdes Sainero‐Alcolado, Muhammad Mushtaq, Judit Liaño-Pons, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 10
Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification
Jyotirmayee Talapatra, Mamatha M. Reddy
Cancers (2023) Vol. 15, Iss. 7, pp. 2144-2144
Open Access | Times Cited: 5
Triple Therapy with Metformin, Ketogenic Diet, and Metronomic Cyclophosphamide Reduced Tumor Growth in MYCN-Amplified Neuroblastoma Xenografts
Luca Catalano, Sepideh Aminzadeh-Gohari, Daniela D. Weber, et al.
Metabolites (2023) Vol. 13, Iss. 8, pp. 910-910
Open Access | Times Cited: 5
Metabolic targeting of neuroblastoma, an update.
Leila Jahangiri
Cancer Letters (2024), pp. 217393-217393
Open Access | Times Cited: 1
GDPD5 Related to Lipid Metabolism Is a Potential Prognostic Biomarker in Neuroblastoma
Tengling Luo, Junwei Peng, Qijun Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13740-13740
Open Access | Times Cited: 7
The opportunities and challenges for nutritional intervention in childhood cancers
Kaiyue Wang, Tianyou Yang, Yubin Zhang, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 3
Acetyl-CoA Carboxylase Inhibitor CP640.186 Increases Tubulin Acetylation and Impairs Thrombin-Induced Platelet Aggregation
Marie Octave, Laurence Pirotton, Audrey Ginion, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 13129-13129
Open Access | Times Cited: 5
Unsaturated fatty acid synthesis is associated with poor prognosis and differentially regulated byMYCNand tumor suppressor microRNAs in neuroblastoma
Dennis A. Sheeter, Secilia Garza, Hui Gyu Park, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Discovery of metabolomic biomarkers for discriminating platinum-sensitive and platinum-resistant ovarian cancer by using GC-MS
Evren Çağlar Eroğlu, Şule Tunuğ, Ömer Faruk Geçkil, et al.
European Journal of Mass Spectrometry (2021) Vol. 27, Iss. 6, pp. 235-248
Closed Access | Times Cited: 3
Page 1

Scroll to top